About AMO Pharma

The company intends to use the funds to advance two clinical-stage pipeline assets targeting rare muscular and central nervous system disorders and to expand the AMO Pharma pipeline through acquisition of additional development-stage products.

Repeat Founder
Elite School Alumni
Top 100 in Health Care in United Kingdom
Top 100 in Pharmaceutical in United Kingdom
Top 100 in Biotechnology in United Kingdom
Company Highlights
Year Founded

2015

icon-altEmployees

10

Location (HQ)

USA

Since Last Funding

8 years 11 months

Monthly Website Visitors

16.4K

icon-altTotal Investment Amt

$25M

Last Funding Round

Series A

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Pharmaceutical Manufacturing

Pharmaceuticals

Pharmaceutical